Simulation training in anaesthesia residency
This trial studies a new way to train doctors in anaesthesia using simulation. It is specifically for people who represent the WFSA.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a representative of the World Federation of Societies of Anaesthesiologists (WFSA).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses simulation to help resident doctors improve their skills in anesthesia and intensive care. Participants are representatives of a special anesthesia training group.
This study tests whether practicing emergency response to postpartum hemorrhage (severe bleeding after childbirth) using realistic simulation improves how anesthesia teams work together. If you're a senior anesthesiology resident, your participation helps develop better training methods.
This trial tests a simulation training program to help surgical residents (non-anesthesiologists) recognize and manage a rare but serious reaction to numbing medicine called local anesthetic systemic toxicity. Participation involves a team practice session to improve emergency readiness.
This study tests if virtual reality (VR) training helps third-year medical students learn anesthesia skills better during their rotation. It compares using a VR simulation to standard training methods.
This study teaches midwives hands-on childbirth skills using practice mannequins and realistic scenarios. It aims to see if this training improves how well midwives care for pregnant patients and handle labor complications.
This trial tests a structured simulation training program for surgeons learning open vascular surgery. It compares the program to standard training to see if it helps residents improve their skills.
Hear when a new Education trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.